Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma
Leukemia & Lymphoma(2020)
Abstract
Histologic transformation of indolent lymphomas account for 13% of de novo presentations of diffuse large B-cell lymphoma (DLBCL) [1]. Although historically associated with poor outcomes in compari...
MoreTranslated text
Key words
cell lymphoma,maintenance rituximab
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined